Table 5 Univariate analysis of the correlation between baseline lymphocyte subsets and PFS in 125 lung cancer participants
| Â | PFS[Month, (95%CI)] | Log rank | P |
|---|---|---|---|
Gender | Â | 3.862 | 0.049 |
 Male | 8.50 (7.02–9.98) |  |  |
 Female | 10.00 (6.71–13.29) |  |  |
Age | Â | 0.877 | 0.349 |
 < 65 | 9.00 (7.44–10.56) |  |  |
 ≥ 65 | 8.50 (6.78–10.22) |  |  |
Smoker | Â | 1.481 | 0.244 |
 No | 9.00 (6.60–11.40) |  |  |
 Yes | 8.50 (7.53–9.47 |  |  |
Histology | Â | 1.004 | 0.316 |
 Adenocarcinoma | 9.50 (8.21–10.80) |  |  |
 Squamous cell carcinoma | 7.50 (6.15–8.85) |  |  |
Distant metastasis | Â | 0.037 | 0.848 |
 No | 10.00 (7.43–12.58) |  |  |
 Yes | 8.50 (7.58–9.42) |  |  |
PD-L1 expression | Â | 5.034 | 0.025 |
 < 50% | 7.00 (6.68–10.32) |  |  |
 ≥ 50% | 9.00 (7.00–13.01) |  |  |
CD4+ T | Â | 4.093 | 0.043 |
 Low proportion group (< 34.30%) | 7.50 (6.41–8.60) |  |  |
 High proportion group (≥  34.30%) | 10.00 (8.48–11.52) |  |  |
CD8+ T | Â | 1.363 | 0.243 |
 Low proportion group (< 31.80%) | 10.00 (7.59–12.43) |  |  |
 High proportion group (≥ 31.80%) | 8.50 (7.08–9.92) |  |  |
CD4+/CD8+ | Â | 4.126 | 0.042 |
 Low ratio group (< 1.07) | 8.00 (7.00–9.00) |  |  |
 High ratio group (≥ 1.07) | 12.00 (9.63–14.37) |  |  |
NK | Â | 4.212 | 0.040 |
 Low proportion group (< 18.90%) | 7.50 (6.08–8.92) |  |  |
 High proportion group (≥ 18.90%) | 10.00 (8.82–11.18) |  |  |
Tregs | Â | 2.783 | 0.095 |
 Low proportion group (< 6.10%) | 7.50 (6.63–8.37) |  |  |
 High proportion group (≥ 6.10%) | 10.00 (8.35–11.65) |  |  |
B | Â | 0.641 | 0.423 |
 Low proportion group (< 7.20%) | 10.00 (7.97–12.03) |  |  |
 High proportion group (≥ 7.20%) | 8.50 (7.33–9.67) |  |  |